Regenerex delivers a complete chronic wound closure program for State, Federal and managed care organizations, and managed care provider groups. We implement these solutions in a capitated, value-based contract environment.
The Regenerex Pharma Complete Wound Closure Program provides a complete turnkey system with the following components:
Regenerex is continuously testing for safety and efficacy.
If you have questions regarding our payer capitated, value-based program, please contact us directly.
Regenerex Pharma, Inc. was incorporated in 2021. Regenerex has corporate offices located in Gordansville, Tennessee and a manufacturing facility in Memphis, Tennessee.